Duration of Anticoagulation Treatment in Patients With Venous Thromboembolism

Scott Kaatz, DO, MSc; Waqas Qureshi, MD; Christopher Fain, DO; and David Paje, MD
Notes and Affiliations
Notes and Affiliations

Received: June 1, 2010

Accepted: September 9, 2010

Published: November 1, 2010

J Osteopath Med; 110(11): 638-644

Deep vein thrombosis and pulmonary embolism are clinical manifestations of venous thromboembolism, and they necessitate anticoagulant therapy in most cases. The duration of treatment is predicated on a balance between the risk of recurrent disease and the risk of bleeding inherent to anticoagulant therapy. It is important that physicians are aware of evidence-based guidelines that can enhance decision-making discussions with patients about the risks and benefits of the different durations of treatment. Keeping patients well informed as they consider these difficult choices helps them assume responsibility and may improve compliance in accordance with the tenets of osteopathic principles of care.

Read Full Article